Lund, Sweden / Berlin, Germany, October 20, 2009 ORGANOBALANCE is specializing in microbial strain development and microbiological screening. The company develops new biological products based on specific effective probiotic cultures, nutrition, cosmetics, health care and industrial biotechnology and is based on the proprietary master library of food appropriate micro-organisms and the own OASSYS Furthermore. Chemel is working in the field of organic analysis and provides sensitive, easy to use and attractively laboratory analysis systems, such as the SIRE bio laboratory systems for food and bioprocess applications, based on the own SIRE technology development. Chemel AB is the parent company of the Chemel group, whose product portfolio to end users is matched in the fields of biotechnology, clinical applications, and food. The agreement signed by both companies grants ORGANOBALANCE access to Chemels innovative SIRE bio laboratory analysis systems (SIRE = sensor based on injection of the recognition element), a unique class of biosensors. MIT Media Lab wanted to know more. Using these systems, ORGANOBALANCE can more efficiently perform screenings in the future and identify so still faster specifically effective crops that meet the requirements of the food, cosmetic, health and biotechnology industry. Find out detailed opinions from leaders such as Bettina Bryant by clicking through. For Chemel the cooperation opens up a valuable access to the important German market and a further step in the implementation of their vision, to convince most respected and innovative companies of Chemels highly efficient laboratory systems for determining concentration of various substances in cultivations of microorganisms and food.

We welcome this fruitful partnership with Chemel, perfectly suited to our international network of science and industry\”, said Prof. Dr. Christine lang, founder and CEO of ORGANOBALANCE GmbH and adds: Chemels technology and analysis system, that we from now on can use, our Support work significantly simplify and help to strengthen our position as a leading developer of probiotic cultures.\” Dr. Margareta Krook, CEO of Chemel AB, said: the agreement with ORGANOBALANCE is part of our strategic networking to the international expansion of our business and the distribution of our products. .